View Session Information

Presenter

SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF FDA ACCESS; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)

Ethics Of Limiting Access To Potentially Promising Technology: At What Point Is It Ethical To Use And Evaluate An Innovative Technology In A Patient/Clinical Study

4:43 PM - 4:48 PM